Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Oral retinoids are effective for various skin conditions but have side effects and should not be used during pregnancy.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Too much topical minoxidil can cause excessive hair growth, but stopping treatment reverses it.

The study concluded that hair loss in Indian women is not significantly linked to anemia or thyroid problems, but checking thyroid function could help those with ongoing hair loss.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Korean patients with rosacea are more likely to have other health conditions.

High-dose oral minoxidil in children can cause increased hair growth, especially on the face.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Low-dose oral minoxidil is a safe treatment for hair loss, with the main side effect being excessive hair growth. Other side effects like foot swelling, low blood pressure when standing, and heart rate changes are rare.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Knuckle Acanthosis Nigricans is common in Latin American youth and may indicate early insulin resistance, especially in those with normal weight.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.